Firms

N & V Capital AG

Drescheweg 2, 9490 Vaduz, Liechtenstein (own current contact address) · Gutenbergstrasse 10, 8002 Zürich, Switzerland (own Zurich branch) · Stuffen Egg 1, 9495 Triesen, Liechtenstein (undated imprint address; current registered-seat verification pending)

nvcapital.li

linkedin.com

N & V Capital AG is the Liechtenstein entrepreneurial single-family office and early-stage venture investor operating nvcapital.li. Its own imprint identifies the exact legal company and public-register number FL-0002.657.542-0; its privacy notice independently confirms the same website operator. The platform invests in the United States and Europe in health and medical technology, artificial intelligence, robotics and space technology. Its own site expressly says it invests from its balance sheet, providing patient capital and flexible decisions rather than operating a traditional externally funded venture fund. The single-family-office investment platform is kept distinct from Indian NV Capital and other N/V-named investors; no regulatory licence, AIF status or beneficial ownership percentage is inferred from the public-register number. No verified founding date was found. The current contact page names Vaduz at Drescheweg 2 and a Zürich branch at Gutenbergstrasse 10. An undated legal imprint gives Stuffen Egg 1 in Triesen, while the privacy notice dated November 2023 gives the earlier Pflugstrasse 16, Vaduz. These source addresses are time-qualified rather than assumed to establish the current registry seat. The exact company identity is consistent across those pages. The complete own published team comprises founding partners Reto Näscher and Yves Vögele; Caglar Bilgin in Investments & Operations; Sandro D’Elia in Advisory & Operations; Fabian Marxer in Finance & Administration; Simone Übele Näscher as Venture Partner for Medtech & Digital Health; and Dr. Robert MacKenzie as Venture Partner for Robotics and AI. Reto’s biography identifies him as co-founder and managing partner, formerly co-founder and CEO of the Prosperity Company before its Fidelidade acquisition. Team biographies describe relevant law, venture finance, sustainability, public administration, medical M&A and robotics engineering expertise. Published external employers and university affiliations are biographical context, not separate N&V employees or personal cash investments. Six genuine individually identified photographs were visually verified; the own Sandro silhouette is a placeholder and is not uploaded. Robert’s illustrated robotics composite was rejected in favour of his genuine self-published professional photograph, corroborated by the identical ANYbotics, Labster and ETH career. The company logo is the original inline navbar vector mark, rasterized without redesign; the homepage’s decorative tree illustration is not used as a logo. Own portfolio descriptions and direct issuer links identify computer-vision cancer-diagnostics company Moonlight AI; AI-assisted medical-product virtual studies at Virtonomy; AI preventive screening at Aeon; AI and LLM product-development software at Elio; AI coaching at Brio; conversational recruitment at Asendia AI; AI systems engineering at Reshape Systems; mixed-reality and AI orthopaedic tools at Claro Surgical; AI ship-cleaning robots at Nautica Technologies; predictive building-control algorithms at Viboo; and deep-technology businesses Odne, Beyond Reach Labs, Forg3D and Pave Space. Nilo is identified as workplace mental-health support. These source-confirmed portfolio relations do not establish a particular financing stage, date, lead status, check amount or individual partner subscription. Other portfolio names and legal/operating aliases are queued for complete independent enrichment. Moonlight AI’s original issuer announcement confirms a completed USD 3.3 million seed financing announced May 6, 2026, naming N&V Capital of Liechtenstein as a participant alongside the three co-leads and existing QAI Ventures. Its own current N&V portfolio entry and investment announcement corroborate the affiliation. Individual N&V ticket and exact subscribing vehicle beyond the named company brand are undisclosed. The company-profile owner records the sole participation on the actual retained issuer event; no duplicate parent, partner or family-office check is inferred. No external-LP fund, actual fund close, AUM, fixed investment budget or published capital ticket range is proven. Corporate balance-sheet investing, portfolio-company total raises and fund-like marketing terms are not converted into invented fundraising cash.

Founded: —
Type: Venture capital